• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性T淋巴细胞相关抗原4(CTLA-4)与B7分子的相互作用足以共刺激T细胞克隆扩增。

CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.

作者信息

Wu Y, Guo Y, Huang A, Zheng P, Liu Y

机构信息

Department of Pathology, New York University Medical Center, New York 10016, USA.

出版信息

J Exp Med. 1997 Apr 7;185(7):1327-35. doi: 10.1084/jem.185.7.1327.

DOI:10.1084/jem.185.7.1327
PMID:9104819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2196265/
Abstract

T cell costimulation, particularly by the B7 family members B7-1 and B7-2, plays a critical role in regulating T cell-mediated immunity. Two molecules on T cells, CD28 and CTLA-4, are known to bind to B7. It has been suggested that CD28-B7 interaction promotes T cell response, whereas B7-CTLA-4 interaction downregulates T cell clonal expansion. However, the proposed responses of individual receptors to B7 have not been verified directly. Here, we report that B7-1 promotes clonal expansion of CD28-deficient T cells, and that the CD28-independent costimulatory activity is mediated by CTLA-4, as it is completely blocked by intact and Fab of anti-CTLA-4 mAb. In addition, a mutant B7-1 molecule, B7W88 >A, which has lost binding to CD28 but retained significant CTLA-4 binding activity, promotes T cell clonal expansion. Furthermore, while presence of CD28 enhances T cell response to B7-1, such response is also completely blocked by anti-CTLA-4 mAb. Taken together, our results demonstrate that B7-CTLA-4 interaction promotes T cell clonal expansion, and that optimal T cell response to B7 is achieved when both CD28 and CTLA-4 interact with B7. These results establish an important function of CTLA-4 in promoting T cell activation, and suggest an alternative interpretation of the function of CTLA-4 in T cell activation.

摘要

T细胞共刺激,尤其是由B7家族成员B7-1和B7-2介导的共刺激,在调节T细胞介导的免疫中起着关键作用。已知T细胞上的两种分子CD28和CTLA-4可与B7结合。有人提出,CD28-B7相互作用促进T细胞反应,而B7-CTLA-4相互作用则下调T细胞克隆扩增。然而,单个受体对B7的上述反应尚未得到直接验证。在此,我们报告B7-1促进CD28缺陷型T细胞的克隆扩增,且不依赖CD28的共刺激活性由CTLA-4介导,因为它完全被抗CTLA-4单克隆抗体的完整抗体和Fab片段所阻断。此外,一种突变的B7-1分子B7W88>A,它失去了与CD28的结合,但保留了显著的CTLA-4结合活性,可促进T细胞克隆扩增。此外,虽然CD28的存在增强了T细胞对B7-1的反应,但这种反应也完全被抗CTLA-4单克隆抗体所阻断。综上所述,我们的结果表明B7-CTLA-4相互作用促进T细胞克隆扩增,并且当CD28和CTLA-4都与B7相互作用时,T细胞对B7能产生最佳反应。这些结果确立了CTLA-4在促进T细胞活化中的重要功能,并提示了对CTLA-4在T细胞活化中功能的另一种解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/1b9492047fb2/JEM.wu8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/d158ebbafb05/JEM.wu1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/dd71b8d80a84/JEM.wu2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/327566db2f18/JEM.wu3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/ef87a62ae4bc/JEM.wu4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/9939383527b1/JEM.wu5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/7378b59af3c1/JEM.wu6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/7e28e56706a1/JEM.wu7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/1b9492047fb2/JEM.wu8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/d158ebbafb05/JEM.wu1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/dd71b8d80a84/JEM.wu2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/327566db2f18/JEM.wu3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/ef87a62ae4bc/JEM.wu4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/9939383527b1/JEM.wu5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/7378b59af3c1/JEM.wu6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/7e28e56706a1/JEM.wu7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/617d/2196265/1b9492047fb2/JEM.wu8.jpg

相似文献

1
CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.细胞毒性T淋巴细胞相关抗原4(CTLA-4)与B7分子的相互作用足以共刺激T细胞克隆扩增。
J Exp Med. 1997 Apr 7;185(7):1327-35. doi: 10.1084/jem.185.7.1327.
2
B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.B7与细胞毒性T淋巴细胞相关抗原4(CTLA4)的相互作用促进体内细胞毒性T淋巴细胞对肿瘤细胞的同源性杀伤。
Blood. 2002 Apr 15;99(8):2880-9. doi: 10.1182/blood.v99.8.2880.
3
The interaction properties of costimulatory molecules revisited.共刺激分子相互作用特性再探讨。
Immunity. 2002 Aug;17(2):201-10. doi: 10.1016/s1074-7613(02)00362-x.
4
Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.通过CD28或CTLA-4选择性作用于人类T细胞的嵌合共刺激分子。
J Biol Chem. 2002 Oct 11;277(41):38660-8. doi: 10.1074/jbc.M205808200. Epub 2002 Aug 6.
5
Absence of B7-dependent responses in CD28-deficient mice.CD28基因缺陷小鼠中缺乏B7依赖性反应。
Immunity. 1994 Sep;1(6):501-8. doi: 10.1016/1074-7613(94)90092-2.
6
B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.B7与CD28的相互作用是人类T细胞反应的一种晚期起作用的共刺激信号。
Int Immunol. 1997 Aug;9(8):1095-102. doi: 10.1093/intimm/9.8.1095.
7
CD28-independent costimulation of T cells in alloimmune responses.同种免疫反应中T细胞的不依赖CD28共刺激
J Immunol. 2001 Jul 1;167(1):140-6. doi: 10.4049/jimmunol.167.1.140.
8
The complexity of the B7-CD28/CTLA-4 costimulatory pathway.B7-CD28/CTLA-4共刺激通路的复杂性。
Agents Actions Suppl. 1998;49:33-43. doi: 10.1007/978-3-0348-8857-8_6.
9
CD28/B7 costimulation: a review.CD28/B7共刺激:综述
Crit Rev Immunol. 1998;18(5):389-418. doi: 10.1615/critrevimmunol.v18.i5.10.
10
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.人B7-1(CD80)和B7-2(CD86)与CD28和CTLA-4受体结合时亲和力相似,但动力学特性不同。
Immunity. 1994 Dec;1(9):793-801. doi: 10.1016/s1074-7613(94)80021-9.

引用本文的文献

1
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma.免疫检查点抑制剂治疗肝细胞癌的现状。
Curr Oncol. 2023 Jun 18;30(6):5863-5875. doi: 10.3390/curroncol30060439.
2
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy.可溶性 CTLA-4 突变体改善免疫相关不良反应,但保留 CTLA-4 和 PD-1 靶向免疫治疗的疗效。
Sci Transl Med. 2023 Mar;15(685):eabm5663. doi: 10.1126/scitranslmed.abm5663. Epub 2023 Mar 1.
3
Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation.

本文引用的文献

1
Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.鉴定一种由CD40L快速诱导产生的共刺激分子,即CD44H。
J Exp Med. 1996 Sep 1;184(3):955-61. doi: 10.1084/jem.184.3.955.
2
Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1).共刺激分子CD80(B7-1)对自然杀伤细胞的激活
Immunity. 1996 Oct;5(4):311-7. doi: 10.1016/s1074-7613(00)80257-5.
3
CTLA-4: a negative regulator of autoimmune disease.细胞毒性T淋巴细胞相关抗原4:自身免疫性疾病的负调节因子。
配体通过 CD28 与 CTLA4 内化后的差异转运促进共刺激的细胞集体控制。
Nat Commun. 2022 Oct 29;13(1):6459. doi: 10.1038/s41467-022-34156-1.
4
Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.靶向细胞外基质进行免疫调节:在药物输送和细胞治疗中的应用。
Drug Deliv Transl Res. 2021 Dec;11(6):2394-2413. doi: 10.1007/s13346-021-01018-0. Epub 2021 Jun 26.
5
Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges.工程纳米颗粒以重新编程放疗和免疫治疗:最新进展和未来挑战。
J Nanobiotechnology. 2020 May 14;18(1):75. doi: 10.1186/s12951-020-00629-y.
6
Insights into CD8 T Cell Activation and Exhaustion from a Mouse Gammaherpesvirus Model.从鼠γ疱疹病毒模型看 CD8 T 细胞的激活和耗竭。
Viral Immunol. 2020 Apr;33(3):215-224. doi: 10.1089/vim.2019.0183.
7
Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy.保留 CTLA-4 检查点以实现更安全、更有效的癌症免疫治疗。
Trends Pharmacol Sci. 2020 Jan;41(1):4-12. doi: 10.1016/j.tips.2019.11.003. Epub 2019 Dec 10.
8
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.重新评估 CTLA-4 检查点阻断在癌症免疫治疗中的作用。
Cell Res. 2018 Apr;28(4):416-432. doi: 10.1038/s41422-018-0011-0. Epub 2018 Feb 22.
9
Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase.RMA-S细胞呈递的抗原密度有限,需要B7-1/CD28信号传导来增强效应阶段的T细胞免疫。
PLoS One. 2014 Nov 10;9(11):e108192. doi: 10.1371/journal.pone.0108192. eCollection 2014.
10
Ligation of cytotoxic T lymphocyte antigen-4 to T cell receptor inhibits T cell activation and directs differentiation into Foxp3+ regulatory T cells.细胞毒性 T 淋巴细胞相关抗原 4 与 T 细胞受体的交联抑制 T 细胞激活,并促使其分化为 Foxp3+调节性 T 细胞。
J Biol Chem. 2012 Mar 30;287(14):11098-107. doi: 10.1074/jbc.M111.283705. Epub 2012 Feb 15.
J Exp Med. 1996 Aug 1;184(2):783-8. doi: 10.1084/jem.184.2.783.
4
CTLA-4 ligation blocks CD28-dependent T cell activation.细胞毒性T淋巴细胞相关抗原4(CTLA-4)的连接阻断了依赖于CD28的T细胞活化。
J Exp Med. 1996 Jun 1;183(6):2541-50. doi: 10.1084/jem.183.6.2541.
5
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.CTLA-4的结合会抑制静息T细胞激活时IL-2的积累和细胞周期进程。
J Exp Med. 1996 Jun 1;183(6):2533-40. doi: 10.1084/jem.183.6.2533.
6
Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement.细胞毒性T淋巴细胞相关抗原4(CTLA-4)的细胞内运输及向T细胞受体(TCR)结合位点的局灶定位
Immunity. 1996 Jun;4(6):535-43. doi: 10.1016/s1074-7613(00)80480-x.
7
Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.酪氨酸磷酸酶SYP与CTLA-4结合对T细胞受体信号传导的调节
Science. 1996 May 24;272(5265):1170-3. doi: 10.1126/science.272.5265.1170.
8
Enhancement of antitumor immunity by CTLA-4 blockade.通过阻断CTLA-4增强抗肿瘤免疫力。
Science. 1996 Mar 22;271(5256):1734-6. doi: 10.1126/science.271.5256.1734.
9
Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.CD40配体对B细胞新型共刺激活性的快速诱导。
Curr Biol. 1995 Nov 1;5(11):1303-11. doi: 10.1016/s0960-9822(95)00257-0.
10
A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.抗原呈递细胞上的一种主要共刺激分子,CTLA4配体A,与B7不同。
J Exp Med. 1993 Nov 1;178(5):1789-93. doi: 10.1084/jem.178.5.1789.